Adjuvant chemotherapy in colorectal carcinoma: Results of a meta- analysis

Diseases of the Colon and Rectum

Volumn 40, Issue 1, 1997, Pages 35-41

  Dube S ^a,b   Heyen, F ^a   Jenicek, M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Adjuvant chemotherapy; Colorectal carcinoma; Meta analysis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031037127     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02055679     Document Type: Article

References (58)

1. Willet CG, Tepper JE, Cohen AM. Failure patterns following curative resection of colonie carcinoma. Ann Surg 1984;200:685-92.
2. Lopez M. Adjuvant therapy of colorectal cancer. Dis Colon Rectum 1994;37(Suppl):S86-91.
3. Levitan N. Chemotherapy in colorectal carcinoma. Surg Clin North Am 1993;73:183-98.
4. Adjuvant therapy for patients with colon and rectum cancer. NIH Consensus Dev Conf Consens Statement 1990;Apr 16-18(4).
5. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer: why we still don't know. JAMA 1988;259;3571-8.
6. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Chimiothérapie adjuvante du cancer colorectal: qu'apprendre d'une méta-analyse? Bull Cancer (Paris) 1989;76: 1021-8.
7. Bruckner HW. Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel [letter]. JAMA 1989; 261:987.
8. Clouse LH. Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel [letter]. JAMA 1989;261:987-8.
9. Chalmers TC, Smith H, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Controlled Clin Trials 1981;2:31-49.
10. Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991;44:127-39.
11. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88.
13. Veterans Administration Adjuvant Cancer Chemotherapy Cooperative Group. The use of 5-fluordeoxyuridine (FUDR) as a surgical adjuvant in carcinoma of the stomach and colorectum. Arch Surg 1963;86:926-31.
14. Dwight R. Adjuvant chemotherapy in cancer of the large bowel: an interim report of the Veterans Administration surgical adjuvant cancer chemotherapy study. Am J Surg 1964;107:609-13.
15. Higgins GA, Dwight RW, Smith JV, Keehn RJ. Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch Surg 1971;102:339-43.
16. Rousselot LM, Cole DR, Grossi CE, Conte AJ, Gonzalez EM, Pasternack BS. Adjuvant chemotherapy with 5-fluorouracil in surgery for colorectal cancer: eight-year progress report. Dis Colon Rectum 1972;15:169-74.
17. Verhaegen H, De Cree J, De Cock W, Verhaegen-Declerq ML, Verbruggen F. Levamisole therapy in patients with colorectal cancer. In: Rosenberg TW, ed. Immunotherapy of human cancer. New York: Elsevier Science, 1982:225-9.
18. Higgins GA, Donaldson RC, Rogers LS, Juler GL, Keehn RJ. Efficacy of MER immunotherapy when added to a regimen of 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. Cancer 1984;54:193-8.
19. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Cancer 1984;54:1811-8.
20. Sparso BH, Von der Maase H, Kristensen D, et al. Complications following postoperative combined radiation and chemotherapy in adenocarcinoma of the rectum and rectosigmoid: a randomized trial that failed. Cancer 1984;54:2363-6.
21. Chlebowski RT, Nystrom S, Reynolds R, Weiner JM, Bateman JR. Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial. Oncology 1988;45: 141-3.
22. Zaniboni A, Erlichman C, Seitz JF, et al. FUFA increases disease-free survival in resected B2C colon cancer: results of a pooled analysis of 3 randomised trials [abstract]. Proc Am Soc Clin Oncol 1993;12:191.
23. Mrazek R, Economou S, McDonald GO, Slaughter DP, Cole WH. Prophylactic and adjuvant use of nitrogen mustard in the surgical traitment of cancer. Ann Surg 1959;150:745-55.
24. Dwight RW, Higgins GA, Keehn RJ. Factors influencing survival after resection in cancer of the colon and rectum. AmJ Surg 1969;117:512-22.
25. Dixon WJ, Longmire WP Jr, Holden WD. Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma: ten-year follow-up. Ann Surg 1971;173:26-39.
26. Dwight RW, Humphrey EW, Higgings GA, Keehn RJ. FUDR as an adjuvant to surgery in cancer of the large bowel. J Surg Oncol 1973;5:243-9.
27. Higgins GA, Humphrey EW, Juler G, LeVeen HH, McCaughan J, Keehn RJ. Adjuvant chemotherapy in the surgical treatment of large bowel cancer. (a) Cancer 1976;38:1461-7.
28. Higgins GA, Humphrey EW, Juler G, LeVeen HH, McCaughan J, Keehn RJ. Adjuvant chemotherapy in the surgical treatment of large bowel cancer. (b) Cancer 1976;38:1461-7.
29. Grossi CE, Wolff WI, Nealon TF Jr, Pasternack B, Ginzburg L, Rousselot LM. Intraluminal fluorouracil chemotherapy adjunct to surgical procedures for resectable carcinoma of the colon and rectum. Surg Gynecol Obstet 1977;145:549-54.
30. Higgings GA Jr, Lee LE Jr, Dwight RW, Keehn RJ. The case for adjuvant 5-fluorouracil in colorectal cancer. Cancer Clin Trials 1978;1:35-41.
31. Lawrence W Jr, Terz JJ, Horsley JS 3d, Brown PW, Romero C. Chemotherapy as an adjuvant to surgery for colorectal cancer: a follow-up report. Arch Surg 1978; 113:164-8.
32. Bancewicz J, Calman KC, Macpherson SG, McArdle SC, McVie JG, Soukop M. Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication. J R Soc Med 1980;73:197-9.
33. Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am 1981; 61:1321-9.
34. Higgings GA Jr, Amadeo JH, McElhinney J, McCaughan JJ, Keehn RJ. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel: a Veterans Administration Surgical Oncology Group report. Cancer 1984;53:1-8.
35. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N Engl J Med 1984;310:737-43.
36. Hafstrom L, Rudenstam CM, Domellof L. A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Astler-Coller Dukes' B and C: results after 5 years observation time. Br J Surg 1985;72:138-41.
37. Wunderlich M, Schiessel R, Rainer H, et al. Effect of adjuvant chemo or immunotherapy on the prognosis of colorectal cancer operated for cure. Br J Surg 1985; 72(Suppl.):S107-10.
38. Gastrointestinal Tumor Study Group. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1985;312:1465-72.
39. Gilbert JM, Hellmann K, Evans M, et al. Randomized trial of oral adjuvant razoxane (ICRF-159) in resectable colorectal cancer: five-year follow-up. Br J Surg 1986; 73:446-50.
40. Irvin T, Vowles KD, Golby MG. Fluorouracil in chemoprophylaxis of colorectal cancer: results of a controlled clinical trial. Dis Colon Rectum 1986;29:704-6.
41. Windle R, Bell PR, Shaw D. Five-year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg 1987;74:569-72.
42. Wolmark N, Fisher B, Rockette H, and other NSABP Investigators. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 1988;80:30-6.
43. Fisher B, Wolmark N, Rockette H, and other NSABP Investigators. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-9.
44. Panettiere FJ, Goodman PJ, Costanzi JJ, et al. Adjuvant therapy in large bowel adenocarcinoma: long-term resuits of a Southwest Oncology Group Study. J Clin Oncol 1988;6:947-54.
45. Arnaud JP, Buyse M, Nordlinger B, et al. Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg 1989;76:284-9.
46. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 1989;7:1447-56.
47. Moertel CG, Fleming TR, MacDonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
48. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991;324:709-15.
49. Wolmark N, Rockette H, Fisher B, et al. Leucovorin-modulated 5-FU (LV-FU) as adjuvant therapy for primary colon cancer [abstract]. NSABP C-03. Proc Am Soc Clin Oncol 1993;12:197.
50. Kingston RD, Fielding JW, Palmer MR. An evaluation of the effectiveness and safety of razoxane when used as an adjunct to surgery in colo-rectal cancer: report of a controlled randomised study of 603 patients. Int J Colorectal Dis 1993;8:106-10.
51. O'Connell M, Mailliard J, MacDonald J, Haller D, Mayer R, Wieand H. An intergroup trial of intensive course 5-FU and low dose leucovorin as surgical adjuvant therapy for high risk colon cancer [abstract]. Proc Am Soc Clin Oncol 1993;12:190.
52. Jenicek M. Meta-analysis in medecine: where we are and where we want to go. J Clin Epidemiol 1989;42:35-44.
53. Macfarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
54. Philips RY, Hittinger R, Blesouwsky L, Fry JS, Fielding LL. Local recurrence following curative surgery for large bowel cancer. I. The overall picture. Br J Surg 1984;71: 12-6.
55. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Ilstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676-82.
56. Chlebowski RT, Lillington L, Nystrom JS, Sayre J. Late mortality and levamisole adjuvant therapy in colorectal cancer. Br J Cancer 1994;69:1094-7.
57. Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
58. Borza KS, Bidker PM. Discordance between meta-analysis and large-scale randomized controlled trials. Ann Intern Med 1995;123:873-7.